Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable

Journal of Hepatology

Volumn 63, Issue 1, 2015, Pages 13-19

  Kefalakes, Helenie ^a   Jochum, Christoph ^a   Hilgard, Gudrun ^a   Kahraman, Alisan ^a   Bohrer, Anna Margarethe ^a   El Hindy, Nicolai ^a   Heinemann, Falko Markus ^a   Verheyen, Jens ^a   Gerken, Guido ^a   Roggendorf, Michael ^b   Timm, Joerg ^a,c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Anti HBs; CD8+ T cell response; HBcAg; HBsAg; HBV core

Indexed keywords

CORE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HLA ANTIGEN CLASS 1; INTERLEUKIN 7 RECEPTOR; VIRUS DNA; HEPATITIS B ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INFECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS LOAD; CHRONIC HEPATITIS B; IMMUNOLOGY; LIVER; MIDDLE AGED; VIROLOGY;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84931567803     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.030     Document Type: Article

References (36)

1. M.K. Maini, C. Boni, G.S. Ogg, A.S. King, S. Reignat, and C.K. Lee Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection Gastroenterology 117 1999 1386 1396
2. R. Thimme, S. Wieland, C. Steiger, J. Ghrayeb, K.A. Reimann, and R.H. Purcell CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 2003 68 76
3. J. Aoki, Y. Kowazaki, T. Ohtsuki, R. Okamoto, K. Ohashi, and S. Hayashi Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation J Gastroenterol 48 2013 728 737
4. B. Rehermann, P. Fowler, J. Sidney, J. Person, A. Redeker, and M. Brown The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis J Exp Med 181 1995 1047 1058
5. B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat Med 2 1996 1104 1108
6. A. Penna, F.V. Chisari, A. Bertoletti, G. Missale, P. Fowler, and T. Giuberti Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen J Exp Med 174 1991 1565 1570
7. M.T. Chen, J.N. Billaud, M. Sallberg, L.G. Guidotti, F.V. Chisari, and J. Jones A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen Proc Natl Acad Sci U S A 101 2004 14913 14918
8. P. Fisicaro, C. Valdatta, M. Massari, E. Loggi, E. Biasini, and L. Sacchelli Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B Gastroenterology 138 2010 682 693 693, e681-e684
9. B. Bengsch, B. Martin, and R. Thimme Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation J Hepatol 61 2014 1212 1219
10. A. Schurich, P. Khanna, A.R. Lopes, K.J. Han, D. Peppa, and L. Micco Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection Hepatology 53 2011 1494 1503
11. A.R. Lopes, P. Kellam, A. Das, C. Dunn, A. Kwan, and J. Turner Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection J Clin Invest 118 2008 1835 1845
12. C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, and S. Schivazappa Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 143 2012 e969
13. A.D. Kosinska, E. Zhang, L. Johrden, J. Liu, P.L. Seiz, and X. Zhang Combination of DNA prime-adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model PLoS Pathog 9 2013 e1003391
14. J. Liu, E. Zhang, Z. Ma, W. Wu, A. Kosinska, and X. Zhang Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection PLoS Pathog 10 2014 e1003856
15. M.S. Abdel-Hakeem, and N.H. Shoukry Protective immunity against hepatitis C: many shades of gray Front Immunol 5 2014 274
16. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, and A. Liebetrau Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 2000 578 582
17. K. Kakimi, M. Isogawa, J. Chung, A. Sette, and F.V. Chisari Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections J Virol 76 2002 8609 8620
18. G.J. Webster, S. Reignat, D. Brown, G.S. Ogg, L. Jones, and S.L. Seneviratne Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy J Virol 78 2004 5707 5719
19. S.M. Kaech, J.T. Tan, E.J. Wherry, B.T. Konieczny, C.D. Surh, and R. Ahmed Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells Nat Immunol 4 2003 1191 1198
20. B. Rehermann, D. Lau, J.H. Hoofnagle, and F.V. Chisari Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J Clin Invest 97 1996 1655 1665
21. F.M. Heinemann HLA genotyping and antibody characterization using the luminex multiplex technology Transfus Med Hemother 36 2009 273 278
22. G. Ren, S. Esser, C. Jochum, J.F. Schlaak, G. Gerken, and D. Schadendorf Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1 Aids 26 2012 2145 2153
23. S. Giugliano, F. Oezkan, M. Bedrejowski, M. Kudla, M. Reiser, and S. Viazov Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3 Hepatology 50 2009 707 716
24. G.M. Lauer, E. Barnes, M. Lucas, J. Timm, K. Ouchi, and A.Y. Kim High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection Gastroenterology 127 2004 924 936
25. E.J. Wherry T cell exhaustion Nat Immunol 12 2011 492 499
26. B. Raziorrouh, W. Schraut, T. Gerlach, D. Nowack, N.H. Gruner, and A. Ulsenheimer The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function Hepatology 52 2010 1934 1947
27. G. Nebbia, D. Peppa, A. Schurich, P. Khanna, H.D. Singh, and Y. Cheng Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection PLoS One 7 2012 e47648
28. C. Boni, P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, and T. Giuberti Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 81 2007 4215 4225
29. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
30. M. Levrero, T. Pollicino, J. Petersen, L. Belloni, G. Raimondo, and M. Dandri Control of cccDNA function in hepatitis B virus infection J Hepatol 51 2009 581 592
31. A. Tamori, M. Hino, E. Kawamura, H. Fujii, S. Uchida-Kobayashi, and H. Morikawa Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy J Gastroenterol Hepatol 29 2014 1715 1721
32. S.N. Pei, C.H. Chen, C.M. Lee, M.C. Wang, M.C. Ma, and T.H. Hu Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients Ann Hematol 89 2010 255 262
33. D. Peppa, U.S. Gill, G. Reynolds, N.J. Easom, L.J. Pallett, and A. Schurich Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion J Exp Med 210 2013 99 114
34. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 2005 215 229
35. H.C. Xu, M. Grusdat, A.A. Pandyra, R. Polz, J. Huang, and P. Sharma Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity Immunity 40 2014 949 960
36. J. Crouse, G. Bedenikovic, M. Wiesel, M. Ibberson, I. Xenarios, and D. Von Laer Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1 Immunity 40 2014 961 973